When I was a child, I was afraid of looking at my transcript

Growing up, I'm afraid of reading medical examination reports

This' Physical Examination Report for Contemporary People '

It's the truth

When people receive a physical examination report and see symptoms such as "fatty liver", "kidney stones", "stomach ulcers", "positive for Helicobacter pylori" in their stomach... even the strongest person in their heart will have an epic drama in their heart:

Who hasn't had an abnormal indicator these days

Wait, these things won't cause cancer, right

I dare not say anything else, but Helicobacter pylori is indeed a heavyweight player listed as a confirmed carcinogen by international official organizations

Source: Eight Substances Added to 15th Report on Carcinogens [1]

The only microorganism that can live in the stomach

Helicobacter pylori is a Gram negative, microaerophilic bacterium that is unipolar, multi flagellar, blunt ended, and spiral shaped. It prefers strong acids and often colonizes the stomach and duodenum of the human body, with significant impacts on human health. Research on Helicobacter pylori can be traced back to the 19th century.

Helicobacter pylori infection proliferates extensively in the stomach, which can greatly damage the gastric mucosa and even the muscle layer, leading to gastric ulcers. Repeated infections may also trigger gastric cancer. At present, there is a broad consensus among doctors and scholars at home and abroad on the importance of anti Helicobacter pylori infection treatment, but there is a lack of more effective intervention methods. Therefore, how to fight against Helicobacter pylori more safely, effectively, and conveniently has always been a hot topic in research.

What constitutes an effective plan to combat Helicobacter pylori?

French experts have publicly pointed out that a good plan to combat Helicobacter pylori requires the following two factors:

·Effective rate>90%

The general treatment methods for Helicobacter pylori are mostly aimed at forced relief of symptoms and require long-term treatment. The current quadruple therapy, which includes one proton pump inhibitor PPI, one bismuth agent, and two antibiotics, has an eradication rate of about 80% to 95% and takes 10 to 14 days to treat. This has certain requirements for antibiotic resistance, compliance, and side effects, leading to a reduction in eradication rates to around 60% -85%, and not all Helicobacter pylori infected individuals are suitable for this plan.

·safety

① No side effects (such as nausea, loss of appetite, weight loss, constipation, black stool, metallic taste in the mouth)

② The patient has high compliance and is easy to adhere to

③ Has minimal impact on gut microbiota and does not cause antibiotic resistance in other bacteria.

What is the 2023 Anti You New Plan?

Of course, it is Postbiocare, a targeted anti gastric protection gene ®

The 2022 Chinese Guidelines for the Treatment of Helicobacter pylori Infection mentioned that probiotics can be used in combination with antibiotic therapy during initial infection and subsequent treatment in patients with unstable gut microbiota. Postbiotics are processed probiotics with clear molecular composition and good safety, avoiding problems such as immune response and transmission of resistance genes caused by live bacteria. They are not affected by heating and pH value, and can be used in combination with antibiotics to amplify the benefits of probiotics. They directly supplement the final functional molecules of probiotics and have a positive effect on preventing and inhibiting Helicobacter pylori infection.

Dr. Peng Chuantao, an outstanding scientist in the field of epigenetics in China, and his team are also conducting specialized research on combating Helicobacter pylori. After 5 years of innovative research and development in Helicobacter pylori suppression technology, they have developed Postbiocare, a next-generation technology ®， This raw material can target the inhibition of Helicobacter pylori because it can form a polymer with Helicobacter pylori and be excreted from the body.

This is the first time in China that a new plan has been implemented to combat Helicobacter pylori in the field of epigenetic development. As we all know, Helicobacter pylori is one of the bacteria with the highest infection rate in the world and is also a representative pathogen of "difficult to treat". Therefore, the significance of this targeted anti Helicobacter pylori research is significant.

In vitro experiments have found that whether used for prevention, initial inhibition of Helicobacter pylori, or in combination with therapy, Postbiocare is a derivative of Postbiocare ® Both can have a positive effect, with an inhibition rate twice that of other products on the market, highly praised by peers, and considered a new generation of Postbiocare ® It may be a new type of anti gastric therapy that is superior to traditional antibiotic therapy.

In addition, multiple clinical trials have been conducted on Helicobacter pylori infected individuals in children and the elderly, and Postbiocare has been given to them ® The affirmation of the effect.

Moreover, the incidence of adverse reactions is extremely low, there is better treatment compliance, and treatment costs are greatly reduced, making it easier for patients to accept.

Bloomberg ProbioticsPostbiocare's Postbiocare beverage is about to be launched

Targeted Anti Gastrointestinal Postbiocare ® Once the raw materials were launched, they immediately attracted high attention from the Helicobacter pylori infected population, who urgently inquired about when the products related to Yuanda Biology could be launched. It is exciting to note that currently, Dr. Peng Chuantao's team has launched Postbiocare ® The raw materials have been industrialized and developed into an anti youyu and stomach protection product solution - Bloomberg Probiotics Postbiocare Postbiocare Postbiocare, which inhibits the adhesion of youyu bacteria, improves the pH environment in the stomach, and gently removes youyu without harming the stomach. At the same time, epigenetic changes can alter the microenvironment of the stomach, hinder the colonization of Helicobacter pylori, and provide more and higher quality anti Helicobacter pylori treatment options for groups with Helicobacter pylori infection and gastric protection needs, bringing more hope to patients.

Suitable for

Antibiotic resistant population

Combining antibiotics to enhance the cure rate among the population

People who do not want or cannot take antibiotics to prevent or prevent recurrence

People with superficial gastritis and other stomach discomfort who need to prevent Helicobacter pylori in advance